LeMaitre to Participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Rhea-AI Summary

LeMaitre (Nasdaq: LMAT) announced that its management will participate in investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026. The event will be held in a virtual format.

Market Context

Recent records showed Net Selling, including a 27,881-share sale by George W LeMaitre. Against that ...

Analysis

Recent records showed Net Selling, including a 27,881-share sale by George W LeMaitre. Against that backdrop, this scheduling notice supplied no reported operating or financial update; conference commentary remained the key item to monitor.

Key Figures

Conference edition: 11th annual Investor meetings date: August 11, 2026

2 metrics

Conference edition 11th annual Needham Virtual MedTech & Diagnostics 1x1 Conference

Investor meetings date August 11, 2026 Needham Virtual MedTech & Diagnostics 1x1 Conference

Historical Context

5 past events · Latest: Jul 14 (Neutral)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Jul 14	Earnings date notice	Neutral	+2.0%	Announced Q2 2026 results release date and conference call schedule
May 20	Investor conferences	Neutral	-1.9%	Announced participation in two June healthcare investor conferences
May 07	Healthcare conference	Neutral	+0.0%	Scheduled management presentation at the Bank of America conference
May 05	Q1 earnings report	Positive	-1.6%	Reported higher sales, margins, operating income, EPS, and cash balance
Apr 14	Earnings date notice	Neutral	-2.2%	Announced Q1 2026 results release date and conference call schedule

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Conference notices produced mixed reactions, including -1.88% and 0.03%, while the Q1 results announcement was followed by a -1.59% reaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BURLINGTON, Mass., Aug. 06, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will hold investor meetings at the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on Tuesday, August 11, 2026.

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

Contact:
Sandra Millar
LeMaitre Vascular, Inc.
+1-781-425-1686
smillar@lemaitre.com

FAQ

When will LeMaitre (LMAT) attend the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference?

LeMaitre management is scheduled to hold investor meetings on Tuesday, August 11, 2026. According to LeMaitre, these meetings will take place during the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference, which is being held in a fully virtual format.

What is the purpose of LeMaitre (LMAT) participating in the Needham Virtual MedTech & Diagnostics 1x1 Conference 2026?

LeMaitre management will participate to hold investor meetings at the conference. According to LeMaitre, these 1x1 meetings at the 11th Annual Needham Virtual MedTech & Diagnostics event facilitate direct discussions with investors in a virtual setting on August 11, 2026.

Is LeMaitre's appearance at the 2026 Needham MedTech & Diagnostics 1x1 Conference in person or virtual?

LeMaitre will attend the conference in a virtual format. According to LeMaitre, management will conduct investor meetings online as part of the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026.

Who from LeMaitre (NASDAQ: LMAT) will be at the Needham Virtual MedTech & Diagnostics 1x1 Conference in August 2026?

LeMaitre stated that its management team will hold investor meetings at the event. According to LeMaitre, company management will participate in the 11th Annual Needham Virtual MedTech & Diagnostics 1x1 Conference on August 11, 2026, in a virtual environment.

How might LeMaitre's (LMAT) participation in the Needham Virtual MedTech & Diagnostics 1x1 Conference impact investors?

Participation provides investors a scheduled opportunity to meet directly with LeMaitre management. According to LeMaitre, these virtual 1x1 meetings on August 11, 2026, are designed for investor interaction, though no specific financial or strategic updates were disclosed in the announcement.